Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: single-dose studies by the intravenous, intramuscular, and oral routes.

× No keyword cloud information.

31 in total

1. The formulation and testing of models.

Authors: M BERMAN
Journal: Ann N Y Acad Sci Date: 1963-05-10 Impact factor: 5.691

2. Intracellular acidbase relations and intracellular buffers.

Authors: E D ROBIN; R J WILSON; P A BROMBERG
Journal: Ann N Y Acad Sci Date: 1961-06-17 Impact factor: 5.691

3. The discovery of librium.

Authors: L H Sternbach
Journal: Agents Actions Date: 1972-06

4. An integrated approach to the pharmacokinetic analysis of drug absorption.

Authors: A E Till; L Z Benet; K C Kwan
Journal: J Pharmacokinet Biopharm Date: 1974-12

5. Influence of route of administration on drug availability.

Authors: M Rowland
Journal: J Pharm Sci Date: 1972-01 Impact factor: 3.534

6. Drug elimination and apparent volume of distribution in multicompartment systems.

Authors: M Gibaldi; D Perrier
Journal: J Pharm Sci Date: 1972-06 Impact factor: 3.534

7. Use of cannulated everted intestinal sac for serial sampling as a drug absorbability (permeability) screen.

Authors: S A Kaplan; S Cotler
Journal: J Pharm Sci Date: 1972-09 Impact factor: 3.534

8. Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

Authors: S Riegelman; J C Loo; M Rowland
Journal: J Pharm Sci Date: 1968-01 Impact factor: 3.534

9. Influence of magnesium and aluminum hydroxide mixture on chlordiazepoxide absorption.

Authors: D J Greenblatt; R I Shader; J S Harmatz; K Franke; J Koch-Weser
Journal: Clin Pharmacol Ther Date: 1976-02 Impact factor: 6.875

10. Calculation of intracellular pH from the distribution of 5,5-dimethyl-2,4-oxazolidinedione (DMO); application to skeletal muscle of the dog.

Authors: W J WADDELL; T C BUTLER
Journal: J Clin Invest Date: 1959-05 Impact factor: 14.808

16 in total

Review 1. Relationships between CSF drug concentrations, receptor binding characteristics, and pharmacokinetic and pharmacodynamic properties of selected 1,4-substituted benzodiazepines.

Authors: W A Colburn; M L Jack
Journal: Clin Pharmacokinet Date: 1987-09 Impact factor: 6.447

2. Drug kinetics and artificial kidneys.

Authors: T B Gibson; H A Nelson
Journal: Clin Pharmacokinet Date: 1977 Nov-Dec Impact factor: 6.447

Review 3. Clinical pharmacokinetics of non-opiate abused drugs.

Authors: U Busto; R Bendayan; E M Sellers
Journal: Clin Pharmacokinet Date: 1989-01 Impact factor: 6.447

4. Chlordiazepoxide metabolite accumulation in liver disease.

Authors: K Barton; P W Auld; M G Scott; D P Nicholls
Journal: Med Toxicol Adverse Drug Exp Date: 1989 Jan-Feb

5. Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. III. Peripheral bioavailability and distribution time concepts applied to the evaluation of distribution kinetics.

Authors: P Veng-Pedersen; W R Gillespie
Journal: J Pharmacokinet Biopharm Date: 1987-06

6. Comparative pharmacokinetics of benzodiazepines in dog and man.

Authors: H Boxenbaum
Journal: J Pharmacokinet Biopharm Date: 1982-08

7. Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: multiple-dose oral administration.

Authors: H G Boxenbaum; K A Geitner; M L Jack; W R Dixon; S A Kaplan
Journal: J Pharmacokinet Biopharm Date: 1977-02

Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: single-dose studies by the intravenous, intramuscular, and oral routes.